Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.

Zalenskaya IA, Chandra N, Yousefieh N, Fang X, Adedipe OE, Jackson SS, Anderson SM, Mauck CK, Schwartz JL, Thurman AR, Doncel GF.

J Clin Invest. 2018 Oct 1;128(10):4622-4638. doi: 10.1172/JCI120583. Epub 2018 Sep 17.

2.

The Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate users.

Thurman A, Schwartz JL, Brache V, Chen BA, Chandra N, Kashuba ADM, Weiner DH, Mauck C, Doncel GF.

J Acquir Immune Defic Syndr. 2018 Sep 11. doi: 10.1097/QAI.0000000000001864. [Epub ahead of print]

PMID:
30212395
3.

Singlet Fission in Covalent Terrylenediimide Dimers: Probing the Nature of the Multiexciton State Using Femtosecond Mid-Infrared Spectroscopy.

Chen M, Bae YJ, Mauck CM, Mandal A, Young RM, Wasielewski MR.

J Am Chem Soc. 2018 Jul 25;140(29):9184-9192. doi: 10.1021/jacs.8b04830. Epub 2018 Jul 11.

PMID:
29949371
4.

Probing Distance Dependent Charge-Transfer Character in Excimers of Extended Viologen Cyclophanes Using Femtosecond Vibrational Spectroscopy.

Wu Y, Zhou J, Phelan BT, Mauck CM, Stoddart JF, Young RM, Wasielewski MR.

J Am Chem Soc. 2017 Oct 11;139(40):14265-14276. doi: 10.1021/jacs.7b08275. Epub 2017 Sep 29.

PMID:
28880547
5.

A phase I randomized postcoital testing and safety study of the Caya diaphragm used with 3% Nonoxynol-9 gel, ContraGel or no gel.

Mauck CK, Brache V, Kimble T, Thurman A, Cochon L, Littlefield S, Linton K, Doncel GF, Schwartz JL.

Contraception. 2017 Aug;96(2):124-130. doi: 10.1016/j.contraception.2017.05.016. Epub 2017 Jun 9.

PMID:
28606382
6.

Photoinduced electron transfer from rylenediimide radical anions and dianions to Re(bpy)(CO)3 using red and near-infrared light.

La Porte NT, Martinez JF, Hedström S, Rudshteyn B, Phelan BT, Mauck CM, Young RM, Batista VS, Wasielewski MR.

Chem Sci. 2017 May 1;8(5):3821-3831. doi: 10.1039/c6sc05103k. Epub 2017 Feb 28.

7.

Spin Polarization Transfer from a Photogenerated Radical Ion Pair to a Stable Radical Controlled by Charge Recombination.

Horwitz NE, Phelan BT, Nelson JN, Mauck CM, Krzyaniak MD, Wasielewski MR.

J Phys Chem A. 2017 Jun 15;121(23):4455-4463. doi: 10.1021/acs.jpca.7b03468. Epub 2017 Jun 2.

PMID:
28531356
8.

Photo-driven electron transfer from the highly reducing excited state of naphthalene diimide radical anion to a CO2 reduction catalyst within a molecular triad.

Martinez JF, La Porte NT, Mauck CM, Wasielewski MR.

Faraday Discuss. 2017 Jun 2;198:235-249. doi: 10.1039/c6fd00219f.

PMID:
28280812
9.

Characterization of Excimer Relaxation via Femtosecond Shortwave- and Mid-Infrared Spectroscopy.

Mauck CM, Young RM, Wasielewski MR.

J Phys Chem A. 2017 Feb 2;121(4):784-792. doi: 10.1021/acs.jpca.6b11388. Epub 2017 Jan 18.

PMID:
28045527
10.

Influence of Anion Delocalization on Electron Transfer in a Covalent Porphyrin Donor-Perylenediimide Dimer Acceptor System.

Hartnett PE, Mauck CM, Harris MA, Young RM, Wu YL, Marks TJ, Wasielewski MR.

J Am Chem Soc. 2017 Jan 18;139(2):749-756. doi: 10.1021/jacs.6b10140. Epub 2017 Jan 9.

PMID:
28026177
11.

Assessment of the vaginal residence time of biomarkers of semen exposure.

Thurman A, Jacot T, Melendez J, Kimble T, Snead M, Jamshidi R, Wheeless A, Archer DF, Doncel GF, Mauck C.

Contraception. 2016 Nov;94(5):512-520. doi: 10.1016/j.contraception.2016.05.012. Epub 2016 May 31.

12.

Singlet Fission via an Excimer-Like Intermediate in 3,6-Bis(thiophen-2-yl)diketopyrrolopyrrole Derivatives.

Mauck CM, Hartnett PE, Margulies EA, Ma L, Miller CE, Schatz GC, Marks TJ, Wasielewski MR.

J Am Chem Soc. 2016 Sep 14;138(36):11749-61. doi: 10.1021/jacs.6b05627. Epub 2016 Aug 31.

PMID:
27547986
13.

Effects of Crystal Morphology on Singlet Exciton Fission in Diketopyrrolopyrrole Thin Films.

Hartnett PE, Margulies EA, Mauck CM, Miller SA, Wu Y, Wu YL, Marks TJ, Wasielewski MR.

J Phys Chem B. 2016 Feb 25;120(7):1357-66. doi: 10.1021/acs.jpcb.5b10565. Epub 2016 Feb 10.

PMID:
26820909
14.

Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Mauck C, Chen PL, Morrison CS, Fichorova RN, Kwok C, Chipato T, Salata RA, Doncel GF.

AIDS Res Hum Retroviruses. 2016 May;32(5):443-51. doi: 10.1089/AID.2015.0088. Epub 2016 Jan 26.

15.

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.

MBio. 2015 Sep 1;6(5):e00221-15. doi: 10.1128/mBio.00221-15.

16.

Fast Triplet Formation via Singlet Exciton Fission in a Covalent Perylenediimide-β-apocarotene Dyad Aggregate.

Mauck CM, Brown KE, Horwitz NE, Wasielewski MR.

J Phys Chem A. 2015 Jun 4;119(22):5587-96. doi: 10.1021/acs.jpca.5b01048. Epub 2015 May 26.

PMID:
25961130
17.

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).

Mcgowan I, Cranston RD, Duffill K, Siegel A, Engstrom JC, Nikiforov A, Jacobson C, Rehman KK, Elliott J, Khanukhova E, Abebe K, Mauck C, Spiegel HM, Dezzutti CS, Rohan LC, Marzinke MA, Hiruy H, Hendrix CW, Richardson-Harman N, Anton PA.

PLoS One. 2015 May 5;10(5):e0125363. doi: 10.1371/journal.pone.0125363. eCollection 2015.

18.

Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input.

Schwartz JL, Weiner DH, Lai JJ, Frezieres RG, Creinin MD, Archer DF, Bradley L, Barnhart KT, Poindexter A, Kilbourne-Brook M, Callahan MM, Mauck CK.

Obstet Gynecol. 2015 Apr;125(4):895-903. doi: 10.1097/AOG.0000000000000721.

19.

Comparison of visual and ultraviolet light inspection versus DNA/protein biomarkers to assess product adherence with vaginal microbicide applicators.

Thurman AR, Jacot TA, Kimble TD, Mauck C, Nelson A, Schwartz JL, Doncel GF.

Sex Transm Dis. 2014 Dec;41(12):739-46. doi: 10.1097/OLQ.0000000000000209.

PMID:
25581811
20.

Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 study.

Richardson-Harman N, Hendrix CW, Bumpus NN, Mauck C, Cranston RD, Yang K, Elliott J, Tanner K, McGowan I, Kashuba A, Anton PA.

PLoS One. 2014 Oct 28;9(10):e111507. doi: 10.1371/journal.pone.0111507. eCollection 2014.

21.

A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate.

Yang KH, Hendrix C, Bumpus N, Elliott J, Tanner K, Mauck C, Cranston R, McGowan I, Richardson-Harman N, Anton PA, Kashuba AD.

PLoS One. 2014 Oct 28;9(10):e106196. doi: 10.1371/journal.pone.0106196. eCollection 2014.

22.

Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?

Snead MC, Kourtis AP, Melendez JH, Black CM, Mauck CK, Penman-Aguilar A, Chaney DM, Gallo MF, Jamieson DJ, Macaluso M, Doncel GF.

Contraception. 2014 Aug;90(2):136-41. doi: 10.1016/j.contraception.2014.03.009. Epub 2014 Mar 25.

23.

Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.

Morrison C, Fichorova RN, Mauck C, Chen PL, Kwok C, Chipato T, Salata R, Doncel GF.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):109-17. doi: 10.1097/QAI.0000000000000103.

PMID:
24413042
24.

Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay.

Snead MC, Melendez JH, Kourtis AP, Chaney DM, Brown TM, Black CM, Mauck CK, Schwartz JL, Zenilman JM, Jamieson DJ, Macaluso M, Doncel GF.

Contraception. 2014 Feb;89(2):134-8. doi: 10.1016/j.contraception.2013.09.016. Epub 2013 Nov 12.

25.

Clinical safety and pharmacology trial.

Mauck C, Thurman A, Schwartz J.

Curr Top Microbiol Immunol. 2014;383:79-95. doi: 10.1007/82_2013_355. Review.

PMID:
24173586
26.

Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure.

Mauck CK, Lai JJ, Weiner DH, Chandra N, Fichorova RN, Dezzutti CS, Hillier SL, Archer DF, Creinin MD, Schwartz JL, Callahan MM, Doncel GF.

AIDS Res Hum Retroviruses. 2013 Nov;29(11):1475-86. doi: 10.1089/AID.2012.0345. Epub 2013 Aug 30.

27.

TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studies.

Jacot TA, Zalenskaya I, Mauck C, Archer DF, Doncel GF.

Contraception. 2013 Sep;88(3):387-95. doi: 10.1016/j.contraception.2012.11.022. Epub 2012 Dec 7.

PMID:
23312930
28.

Twice-daily application of HIV microbicides alter the vaginal microbiota.

Ravel J, Gajer P, Fu L, Mauck CK, Koenig SS, Sakamoto J, Motsinger-Reif AA, Doncel GF, Zeichner SL.

MBio. 2012 Dec 18;3(6). pii: e00370-12. doi: 10.1128/mBio.00370-12.

29.

Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards.

Snead MC, Kourtis AP, Black CM, Mauck CK, Brown TM, Penman-Aguilar A, Melendez JH, Gallo MF, Jamieson DJ, Macaluso M.

Contraception. 2013 Sep;88(3):382-6. doi: 10.1016/j.contraception.2012.10.034. Epub 2012 Dec 4.

30.

A quantitative glycogen assay to verify use of self-administered vaginal swabs.

Anderson DJ, Politch JA, Pudney J, Marquez CI, Snead MC, Mauck C.

Sex Transm Dis. 2012 Dec;39(12):949-53. doi: 10.1097/OLQ.0b013e31826e880e.

31.

Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.

Chandra N, Thurman AR, Anderson S, Cunningham TD, Yousefieh N, Mauck C, Doncel GF.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):592-601. doi: 10.1089/aid.2012.0271. Epub 2012 Nov 28.

32.

RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate.

Anton PA, Cranston RD, Kashuba A, Hendrix CW, Bumpus NN, Richardson-Harman N, Elliott J, Janocko L, Khanukhova E, Dennis R, Cumberland WG, Ju C, Carballo-Diéguez A, Mauck C, McGowan I.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1412-21. doi: 10.1089/AID.2012.0262. Epub 2012 Oct 9.

33.

Dyeing to know: the use of vaginal applicator staining and other techniques to assess adherence to product use in microbicide trials.

Mauck CK, Schwartz JL.

Sex Transm Dis. 2012 Sep;39(9):713-5. doi: 10.1097/OLQ.0b013e318264f6b0. No abstract available.

PMID:
22902668
34.

Dose-response relationship between tissue concentrations of UC781 and explant infectibility with HIV type 1 in the RMP-01 rectal safety study.

Richardson-Harman N, Mauck C, McGowan I, Anton P.

AIDS Res Hum Retroviruses. 2012 Nov;28(11):1422-33. doi: 10.1089/AID.2012.0073. Epub 2012 Sep 20.

35.

Assessment of a Microbicide Candidate among a Diverse Cohort of Urban Southern US Women and their Male Sexual Partners.

Frew P, Parker K, Horton T, Hixson B, Flowers L, Priddy F, Grohskopf L, Mauck C, Workowski K.

J AIDS Clin Res. 2012 Jul 3;Suppl 4(4). pii: S4-004.

36.

Colposcopy: still useful in microbicide safety trials?

Mauck CK, Weiner DH, Lai JJ, Schwartz JL.

Sex Transm Dis. 2012 Jun;39(6):465-9. doi: 10.1097/OLQ.0b013e3182500f33.

PMID:
22592833
37.

First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy.

Anton PA, Saunders T, Elliott J, Khanukhova E, Dennis R, Adler A, Cortina G, Tanner K, Boscardin J, Cumberland WG, Zhou Y, Ventuneac A, Carballo-Diéguez A, Rabe L, McCormick T, Gabelnick H, Mauck C, McGowan I.

PLoS One. 2011;6(9):e23243. doi: 10.1371/journal.pone.0023243. Epub 2011 Sep 28.

38.

Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non-pregnant women in microbicide trials.

Fichorova RN, Lai JJ, Schwartz JL, Weiner DH, Mauck CK, Callahan MM.

Cytokine. 2011 Jul;55(1):134-40. doi: 10.1016/j.cyto.2011.03.016. Epub 2011 May 6.

PMID:
21530305
39.

Reddy female condom: functional performance of a 90-mm shaft length in two clinical studies.

Mauck C, Joshi S, Schwartz J, Callahan M, Walsh T.

Contraception. 2011 May;83(5):466-71. doi: 10.1016/j.contraception.2010.09.015. Epub 2010 Nov 23.

PMID:
21477691
40.

Synthesis and structures of Pb3O2(CH3COO)2·0.5H2O and Pb2O(HCOO)2: two corrosion products revisited.

Mauck CM, van den Heuvel TW, Hull MM, Zeller M, Oertel CM.

Inorg Chem. 2010 Nov 15;49(22):10736-43. doi: 10.1021/ic101904j. Epub 2010 Oct 20.

PMID:
20961144
41.

Results of a safety and feasibility study of the diaphragm used with ACIDFORM Gel or K-Y Jelly.

von Mollendorf CE, Van Damme L, Moyes JA, Rees VH, Callahan MM, Mauck CK, Puren AJ, Tweedy K, Taylor D.

Contraception. 2010 Mar;81(3):232-9. doi: 10.1016/j.contraception.2009.10.011. Epub 2009 Nov 22.

PMID:
20159180
42.

Safety evaluation of 1% tenofovir gel in healthy men.

Schwartz JL, Poindexter A, Wheeless A, Mauck CK, Callahan MM.

Int J STD AIDS. 2009 Jun;20(6):384-6. doi: 10.1258/ijsa.2008.008309.

PMID:
19451321
43.

Critical next steps for female condom research--report from a workshop.

Mauck CK, Weaver MA, Schwartz JL, Walsh T, Joanis C.

Contraception. 2009 May;79(5):339-44. doi: 10.1016/j.contraception.2008.12.005. Epub 2009 Mar 17. No abstract available.

PMID:
19341844
44.

Biomarkers for evaluating vaginal microbicides and contraceptives: discovery and early validation.

Mauck CK.

Sex Transm Dis. 2009 Mar;36(3 Suppl):S73-5. doi: 10.1097/OLQ.0b013e3181994155. Review.

PMID:
19218892
45.

Biomarkers of semen exposure.

Mauck CK.

Sex Transm Dis. 2009 Mar;36(3 Suppl):S81-3. doi: 10.1097/OLQ.0b013e318199413b. Review.

PMID:
19218891
46.

Biomarker discovery: validation and decision-making in product development.

Niedbala RS, Mauck C, Harrison P, Doncel GF.

Sex Transm Dis. 2009 Mar;36(3 Suppl):S76-80. doi: 10.1097/OLQ.0b013e31819cd800. Review.

PMID:
19218888
47.

Comparative crossover study of the PATH Woman's Condom and the FC Female Condom.

Schwartz JL, Barnhart K, Creinin MD, Poindexter A, Wheeless A, Kilbourne-Brook M, Mauck CK, Weiner DH, Callahan MM.

Contraception. 2008 Dec;78(6):465-73. doi: 10.1016/j.contraception.2008.07.020. Epub 2008 Sep 18.

PMID:
19014792
48.

Six-day randomized safety trial of intravaginal lime juice.

Mauck CK, Ballagh SA, Creinin MD, Weiner DH, Doncel GF, Fichorova RN, Schwartz JL, Chandra N, Callahan MM.

J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):243-50. doi: 10.1097/QAI.0b013e318186eae7.

PMID:
18845958
49.

Colposcopically observed vascular changes in the cervix in relation to the hormonal levels and menstrual cycle.

Joshi SN, Das S, Thakar M, Sahasrabuddhe V, Kumar BK, Callahan M, Mauck C.

J Low Genit Tract Dis. 2008 Oct;12(4):293-9. doi: 10.1097/LGT.0b013e31817efbbd.

50.

SILCS diaphragm: postcoital testing of a new single-size contraceptive device.

Schwartz JL, Ballagh SA, Creinin MD, Rountree RW, Kilbourne-Brook M, Mauck CK, Callahan MM.

Contraception. 2008 Sep;78(3):237-44. doi: 10.1016/j.contraception.2008.04.118. Epub 2008 Jul 3.

PMID:
18692615

Supplemental Content

Support Center